Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Next-Generation Agents for ALK-Positive NSCLC
EP. 1: The Evolution of ALK/ROS1-Targeted Therapy in NSCLC
April 27th 2017
EP. 2: Patterns of Progression on Crizotinib for ALK+ NSCLC
April 27th 2017
EP. 3: FDA Approval of Brigatinib for ALK+ NSCLC
April 27th 2017
EP. 4: ALTA II Trial of Brigatinib in ALK-Rearranged NSCLC
April 27th 2017
EP. 5: Repeat Mutation Testing at ALK-Rearranged NSCLC Progression
April 27th 2017
EP. 6: Treatment of Relapsed/Refractory ALK+ NSCLC
April 27th 2017
EP. 7: Upfront Use of Second-Line Agents in ALK+ NSCLC
April 27th 2017
EP. 8: Sequencing Therapies in ALK+ NSCLC
April 27th 2017
EP. 9: Treatment of ALK-Driven Refractory NSCLC
April 27th 2017
EP. 10: Next Generation ALK Inhibitors for NSCLC
April 27th 2017
NEXT PAGE
<
1
2
>
PREVIOUS PAGE